RESUMEN
Occurence of gingival hyperplasia along with the plaque index, gingival index and bleeding index scores of 54 renal transplant recipients and 52 chronic renal failure patients on hemodialysis were evaluated. Renal transplant receipients were on an immunosuppression [I.S.] therapy regimen since the time of transplantation and had a stable renal function during the last three months. No significant differences could be found between the two groups regarding plaque index, gingival index, bleeding index scores and gingival hyperplasia. Among the 44 patients on cyclosporin therapy gingival hyperplasia was observed in 14 patients. Gingival hyperplasia could not be noticed in any of the patients on azathioprine therapy. There was a significant corelation between the occurence of gingival hyperplasia and the plaque index scores in patients receiving cyclosporin therapy. The incidence of gingival hyperplasia seemed to have no significant correlation with the duration of I.S. therapy. Our result showed gingival hyperplasia in 31.82% renal transplant recipients receiving cyclosporin therapy